We are live on ! Find out more
VIGL

Vigil Neuroscience

Delisted

VIGL was delisted on the 4th of August, 2025.

Name Holding Trade Value Shares
Change
Change in
Stake
AVLSA
1
Atlas Venture Life Science Advisors
Massachusetts
$53.1M
NV
2
Northpond Ventures
Maryland
$38.4M
DTC
3
Deep Track Capital
Connecticut
$21.5M +$15.1M +2,054,795 +666%
AG
4
Artal Group
Luxembourg
$20.8M +$8.54M +1,164,383 +104%
Citadel Advisors
5
Citadel Advisors
Florida
$19.7M +$10.5K +1,431 +0.1%
DM
6
Deerfield Management
New York
$18M +$15.1M +2,054,794 New
BI
7
BVF Inc
California
$16.5M +$13.3M +1,813,633 New
CAM
8
Cormorant Asset Management
Massachusetts
$5.61M
PBPIA
9
Pivotal bioVenture Partners Investment Advisor
California
$5.1M
RSCM
10
Rock Springs Capital Management
Maryland
$4.29M
O
11
OrbiMed
New York
$3.74M
Vanguard Group
12
Vanguard Group
Pennsylvania
$3.33M +$82.3K +11,218 +3%
HMC
13
Harvard Management Company
Massachusetts
$2.63M
DCM
14
DAFNA Capital Management
California
$1.97M +$855K +116,641 +117%
LGM
15
Logos Global Management
California
$1.87M
LCM
16
Laurion Capital Management
New York
$1.19M
Barclays
17
Barclays
United Kingdom
$929K +$3.54K +482 +0.5%
BlackRock
18
BlackRock
New York
$926K -$18.3K -2,498 -2%
Goldman Sachs
19
Goldman Sachs
New York
$665K -$389 -53 -0.1%
Geode Capital Management
20
Geode Capital Management
Massachusetts
$653K +$89.3K +12,174 +20%
Citigroup
21
Citigroup
New York
$616K +$19K +2,592 +4%
E
22
Ergoteles
New York
$260K +$209K +28,533 New
Fidelity Investments
23
Fidelity Investments
Massachusetts
$245K +$197K +26,915 +67,288%
Adage Capital Partners
24
Adage Capital Partners
Massachusetts
$203K
State Street
25
State Street
Massachusetts
$195K +$22K +3,000 +16%